0R15 8884.0068 1.4156% 0R1E 9171.0 0.4381% 0M69 None None% 0R2V 254.3746 5.7691% 0QYR 1619.0 1.9521% 0QYP 436.689 -0.8652% 0RUK None None% 0RYA 1604.02 0.4396% 0RIH 190.8 0.0% 0RIH 198.5 4.0356% 0R1O 225.0 9877.8271% 0R1O None None% 0QFP None None% 0M2Z 255.4879 -0.0829% 0VSO 33.09 -7.0636% 0R1I None None% 0QZI 599.0 0.0% 0QZ0 220.0 0.0% 0NZF None None% 0YXG 225.74 -0.2871%
Last update at 2024-12-23T15:46:00Z
Is Persimmon (PSMMY) Outperforming Other Construction Stocks This Year?
Fri 18 Oct 24, 01:40 PMMonthly mortgage payments surged by over £350 in past five years
Fri 11 Oct 24, 05:00 AMUK house prices rise for third straight month amid falling mortgage rates
Mon 07 Oct 24, 07:07 AMWith 81% ownership, Persimmon Plc (LON:PSN) boasts of strong institutional backing
Sun 06 Oct 24, 09:33 AMUK's fastest selling property market revealed
Thu 03 Oct 24, 05:00 AMPersimmon (LON:PSN) Is Reinvesting At Lower Rates Of Return
Thu 19 Sep 24, 09:37 AMHow to buy your first home in a cost of living crisis
Fri 13 Sep 24, 05:00 AMAverage UK house price £3,600 higher since the beginning of 2024
Wed 28 Aug 24, 05:00 AM| Breakdown | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 |
|---|---|---|---|---|---|
| Type | yearly | yearly | yearly | yearly | yearly |
| Date | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 |
| Income before tax | 730.70M | 966.80M | 783.80M | 1040.80M | 1090.80M |
| Minority interest | - | - | - | - | - |
| Net income | 561.00M | 787.20M | 638.40M | 848.80M | 886.40M |
| Selling general administrative | - | - | - | 107.40M | 101.10M |
| Selling and marketing expenses | - | - | - | - | - |
| Gross profit | 867.50M | 1083.80M | 894.40M | 1130.70M | 1179.90M |
| Reconciled depreciation | 15.80M | 14.50M | 14.10M | 13.30M | 10.00M |
| Ebit | 734.80M | 970.40M | 783.50M | 1029.40M | 1103.10M |
| Ebitda | 750.60M | 984.90M | 806.50M | 1063.20M | 1113.10M |
| Depreciation and amortization | 15.80M | 14.50M | 23.00M | 33.80M | 10.00M |
| Non operating income net other | - | - | - | - | - |
| Operating income | 734.80M | 970.40M | 783.50M | 1029.40M | 1082.70M |
| Other operating expenses | 3090.90M | 2650.00M | 2544.80M | 2620.00M | 2654.90M |
| Interest expense | 4.10M | 3.60M | 8.60M | 9.10M | 12.30M |
| Tax provision | 169.70M | 179.60M | 145.40M | 192.00M | 204.40M |
| Interest income | 6.00M | 9.90M | 8.90M | 7.40M | 9.20M |
| Net interest income | 5.80M | 6.30M | 0.30M | 11.40M | 8.10M |
| Extraordinary items | - | - | - | - | - |
| Non recurring | - | - | - | - | - |
| Other items | - | - | - | - | - |
| Income tax expense | 169.70M | 179.60M | 145.40M | 192.00M | 204.40M |
| Total revenue | 3815.80M | 3610.50M | 3328.30M | 3649.40M | 3737.60M |
| Total operating expenses | 142.60M | 123.30M | 110.90M | 101.30M | 97.20M |
| Cost of revenue | 2948.30M | 2526.70M | 2433.90M | 2518.70M | 2557.70M |
| Total other income expense net | -4.10000M | -3.60000M | 0.30M | 11.40M | 8.10M |
| Discontinued operations | - | - | - | - | - |
| Net income from continuing ops | 561.00M | 787.20M | 638.40M | 848.80M | 886.40M |
| Net income applicable to common shares | 561.00M | 787.20M | 638.40M | 848.80M | 886.40M |
| Preferred stock and other adjustments | - | - | - | - | - |
| Breakdown | 2023-06-30 | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 |
|---|---|---|---|---|---|
| Type | yearly | yearly | yearly | yearly | yearly |
| Date | 2023-06-30 | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 |
| Total assets | - | 5034.10M | 4792.20M | 4623.10M | 4489.30M |
| Intangible assets | - | 60.00M | 60.00M | 60.00M | 60.00M |
| Earning assets | - | - | - | - | - |
| Other current assets | - | 221.90M | 155.20M | 109.40M | 67.90M |
| Total liab | - | 1594.80M | 1167.00M | 1104.70M | 1231.00M |
| Total stockholder equity | - | 3439.30M | 3625.20M | 3518.40M | 3258.30M |
| Deferred long term liab | - | - | - | - | - |
| Other current liab | - | 142.10M | 78.20M | 80.50M | 84.50M |
| Common stock | - | 31.90M | 31.90M | 31.90M | 31.90M |
| Capital stock | - | 31.90M | 31.90M | 31.90M | 31.90M |
| Retained earnings | - | 2868.50M | 3055.10M | 2950.90M | 2693.90M |
| Other liab | - | 492.40M | 273.00M | 220.40M | 225.90M |
| Good will | - | 113.00M | 115.60M | 121.80M | 126.10M |
| Other assets | - | 195.80M | 194.80M | 104.00M | 150.50M |
| Cash | - | 861.60M | 1246.60M | 1234.10M | 843.90M |
| Cash and equivalents | - | - | - | - | - |
| Total current liabilities | - | 1091.50M | 885.20M | 874.70M | 996.20M |
| Current deferred revenue | - | - | - | - | - |
| Net debt | - | -861.60000M | -1246.60000M | -1234.10000M | -843.90000M |
| Short term debt | - | - | - | 285.50M | - |
| Short long term debt | - | - | - | - | - |
| Short long term debt total | - | - | - | - | - |
| Other stockholder equity | - | 538.90M | 538.20M | 535.60M | 532.50M |
| Property plant equipment | - | 118.60M | 99.00M | 90.40M | 82.00M |
| Total current assets | - | 4546.40M | 4322.50M | 4244.80M | 4068.60M |
| Long term investments | - | - | - | - | 2.10M |
| Net tangible assets | - | 3266.30M | 3449.60M | 3336.60M | 3072.20M |
| Short term investments | - | - | - | - | - |
| Net receivables | - | 153.70M | 155.20M | 102.80M | 61.90M |
| Long term debt | - | - | - | - | - |
| Inventory | - | 3462.90M | 2920.70M | 2901.30M | 3156.80M |
| Accounts payable | - | 949.40M | 807.00M | 794.20M | 911.70M |
| Total permanent equity | - | - | - | - | - |
| Noncontrolling interest in consolidated entity | - | - | - | - | - |
| Temporary equity redeemable noncontrolling interests | - | - | - | - | - |
| Accumulated other comprehensive income | - | - | - | - | -96.20000M |
| Additional paid in capital | - | - | - | - | - |
| Common stock total equity | - | - | - | 31.90M | 31.90M |
| Preferred stock total equity | - | - | - | - | - |
| Retained earnings total equity | - | - | - | - | - |
| Treasury stock | - | - | - | - | - |
| Accumulated amortization | - | - | - | - | - |
| Non currrent assets other | - | 185.60M | 185.40M | 98.40M | 146.00M |
| Deferred long term asset charges | - | - | - | - | - |
| Non current assets total | - | 487.70M | 469.70M | 378.30M | 420.70M |
| Capital lease obligations | - | - | - | - | - |
| Long term debt total | - | - | - | - | - |
| Breakdown | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 |
|---|---|---|---|---|---|
| Type | yearly | yearly | yearly | yearly | yearly |
| Date | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 |
| Investments | -29.80000M | 1.80M | -18.10000M | 0.90M | 0.90M |
| Change to liabilities | 141.10M | 37.40M | -116.90000M | -225.60000M | -82.70000M |
| Total cashflows from investing activities | -29.80000M | -18.20000M | -18.10000M | -25.90000M | -15.00000M |
| Net borrowings | -3.30000M | -3.30000M | -3.60000M | -3.80000M | -3.80000M |
| Total cash from financing activities | -757.50000M | -754.10000M | -357.20000M | -798.30000M | -893.90000M |
| Change to operating activities | 13.30M | 18.90M | 16.40M | 31.40M | 41.60M |
| Net income | 561.00M | 787.20M | 638.40M | 848.80M | 886.40M |
| Change in cash | -385.00000M | 12.50M | 390.20M | -204.20000M | -254.60000M |
| Begin period cash flow | 1246.60M | 1234.10M | 843.90M | 1048.10M | 1302.70M |
| End period cash flow | 861.60M | 1246.60M | 1234.10M | 843.90M | 1048.10M |
| Total cash from operating activities | 402.30M | 784.80M | 765.50M | 620.00M | 654.30M |
| Issuance of capital stock | 0.70M | 2.60M | 0.70M | 43.30M | 157.10M |
| Depreciation | 15.80M | 14.50M | 14.10M | 13.30M | 10.00M |
| Other cashflows from investing activities | - | - | 0.80M | 1.60M | 0.50M |
| Dividends paid | 750.10M | 749.60M | 350.70M | 747.80M | 732.30M |
| Change to inventory | -532.50000M | -9.80000M | 265.00M | -87.70000M | -225.50000M |
| Change to account receivables | -81.10000M | -59.50000M | -45.80000M | 6.30M | -26.70000M |
| Sale purchase of stock | -0.70000M | - | 3.10M | 3.90M | -1.30000M |
| Other cashflows from financing activities | -7.40000M | -7.10000M | -7.20000M | -7.20000M | -3.20000M |
| Change to netincome | 284.70M | -3.90000M | -5.70000M | 33.50M | 51.20M |
| Capital expenditures | 30.50M | 20.90M | 18.90M | 27.50M | 15.50M |
| Change receivables | - | - | - | - | - |
| Cash flows other operating | - | - | - | - | - |
| Exchange rate changes | - | - | - | - | - |
| Cash and cash equivalents changes | - | - | - | - | - |
| Change in working capital | -459.20000M | -13.00000M | 118.70M | -275.60000M | -293.30000M |
| Stock based compensation | 9.00M | 6.40M | 6.40M | 3.70M | 7.90M |
| Other non cash items | 275.70M | -8.10000M | -9.00000M | -11.30000M | -6.40000M |
| Free cash flow | 371.80M | 763.90M | 746.60M | 592.50M | 638.80M |
Sector: Consumer Cyclical Industry: Residential Construction
| Company | Change (GBP) | Price (GBP) | Trailing PE (x) | Forward PE (x) | Price Sales TTM (x) | Price to Book Value (x) | Enterprise Value to Revenue (x) | Enterprise Value to EBITDA (x) |
|---|---|---|---|---|---|---|---|---|
| PSN Persimmon PLC |
2.50 0.21% | 1214.00 | 13.61 | 16.37 | 1.33 | 1.32 | 1.23 | 8.71 |
| TW Taylor Wimpey PLC |
-0.3 0.25% | 121.85 | 9.07 | 15.41 | 1.28 | 1.14 | 1.13 | 5.85 |
| BKG The Berkeley Group Holdings plc |
-6.0 0.15% | 3892.00 | 11.34 | 13.26 | 1.99 | 1.49 | 1.84 | 7.23 |
| VTY Vistry Group PLC |
-4.5 0.68% | 654.50 | 12.94 | 9.63 | 1.00 | 0.95 | 1.12 | 10.16 |
| BWY Bellway PLC |
-6.0 0.25% | 2392.00 | 8.74 | 20.92 | 0.90 | 0.89 | 0.84 | 5.47 |
Persimmon Plc, together with its subsidiaries, operates as a house builder in the United Kingdom. The company offers family housing under the Persimmon Homes brand name; housing under the Charles Church brand name; and social housing under the Westbury Partnerships brand name. It also provides broadband services under the FibreNest brand; and timber frame, insulated wall panels, and roof cassettes under the brand Space4. Further, it offers concrete bricks and roof tile. Persimmon Plc was founded in 1972 and is headquartered in York, the United Kingdom.
1330 O?Brien Drive, Menlo Park, CA, United States, 94025
| Name | Title | Year Born |
|---|---|---|
| Mr. John Stephen West | Co-Founder, CEO, Pres & Director | 1957 |
| Mr. Aaron L. Tachibana | Sr. VP & CFO | 1961 |
| Dr. Richard Chen M.D., M.S., MS | Sr. VP of R&D and Chief Medical Officer | 1971 |
| Dr. Russ B. Altman M.D., Ph.D. | Co-Founder and Member of Clinical & Scientific Advisory Board | NA |
| Dr. Euan A. Ashley DPHIL, FRCP, M.D., Ph.D. | Co-Founder and Member of Clinical & Scientific Advisory Board | 1972 |
| Dr. Atul Butte | Co-Founder and Member of Clinical & Scientific Advisory Board | NA |
| Dr. Michael Snyder Ph.D. | Co-Founder and Member of Clinical & Scientific Advisory Board | NA |
| Ms. Carol J. Tillis | VP of Fin. & Admin. | NA |
| Mr. Stephen M. Moore J.D. | VP, Gen. Counsel & Corp. Sec. | 1972 |
| Mr. Michael J Fitzpatrick | VP of Worldwide Sales | NA |
Disclaimer - This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on ‘as is’ basis, using their API. The information and data provided on this page, as well as via the API, are not guaranteed to be real-time or accurate. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general informational purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine does not assume any responsibility for any trading losses you might incur as a result of using this information, data, or any analyst rating or recommendation provided. Kalkine will not accept any liability for any loss or damage resulting from reliance on the information, including but not limited to data, quotes, charts, analyst ratings, recommendations, and buy/sell signals sourced via the API.
Please be fully informed about the risks and costs associated with trading in the financial markets, as it is one of the riskiest forms of investment. Kalkine does not provide any warranties regarding the information on this page, including, without limitation, warranties of merchantability or fitness for a particular purpose or use.
UK 
AU
CA
US
NZ
Please wait processing your request...